▶ 調査レポート

世界の灌流システム市場

• 英文タイトル:Perfusion System Market - Growth, Trends, and Forecast (2019 - 2024)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の灌流システム市場 / Perfusion System Market - Growth, Trends, and Forecast (2019 - 2024) / C-MOR-100059資料のイメージです。• レポートコード:C-MOR-100059
• 出版社/出版日:Mordor Intelligence / 2019年9月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Multi User¥703,000 (USD4,750)▷ お問い合わせ
  Site License¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、灌流システムの世界市場について調査・分析し、灌流システムの世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。

Market Overview
The major factors for the growth of the perfusion system market include the rising demand for organ transplantation, increase in the prevalence of cardiovascular and respiratory diseases, and rising initiatives by government and various organizations to promote organ donations.

The rising demand for organ transplantation is the major factor propelling the growth of the market. As per the data published by the United Network for Organ Sharing, in the United States, 113,379 people need a lifesaving organ transplant (total waiting list candidates) as of August 2019. The rising demand for organ transplantation is expected to increase the demand for reliable organ perfusion systems. In addition, there is a rising prevalence of cardiovascular and respiratory diseases across the globe boosting the demand for organ transplantation. As per the data published by the Division of Transplantation (DoT) of the Department of Health and Human Services, Health Resources and Services Administration’s Healthcare Systems Bureau, there were 3,408 heart transplants in 2018. Thus, owing to the rising demand for organ transplantation and an increase in the prevalence of cardiovascular and respiratory diseases the market is expected to witness high growth.

Scope of the Report

As per the scope of this report, perfusion systems are the devices used for the passing of fluid into the circulatory system, an organ or body tissue. The perfusion systems can be used in the transportation and stabilization of organs. The market is segmented by technology, type of organ, and geography.

Key Market Trends

The kidney Segment is expected to Hold Largest Market Share

The rising prevalence of chronic kidney diseases is the major factor driving the growth of the market. As per the National Institute of Diabetes and Digestive and Kidney Disease, the prevalence of Chronic Kidney Disease (CKD) in the United States is about 14%. Similarly, in the United Kingdom as per Kidney Research UK report 2018, it is estimated that 3 million lives are at risk, as a result of moderate to severe chronic kidney disease. An estimated, 1 million people in the United Kingdom have chronic kidney disease but are undiagnosed. Furthermore, machine perfusion techniques demonstrated several benefits when compared with cold storage techniques. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest perfusion system market owing to the rising technological advancements and the presence of better healthcare infrastructure. Furthermore, the rising prevalence of cardiovascular and respiratory diseases increasing the demand of perfusion systems. According to the data published by the United Network for Organ Sharing, there were 19,513 transplants performed as of June 2019. However, the high cost of transplantation and scarcity of donors is the major factor expected to hinder the growth of the market. Thus, owing to the all above-mentioned factors the market is expected to hold the largest market share.

Competitive Landscape

The market studied is a consolidated market owing to the presence of a few major market players. Some of the market players are Bridge to Life (Europe) Ltd., Organ Assist B.V., Organ Recovery Systems, Inc, OrganOx Limited, Paragonix Technologies, Inc., Preservation Solutions Inc, TransMedics, Inc., Waters Medical Systems LLC, and XVIVO Perfusion AB

Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Organ Transplantation
4.2.2 Increase in the Prevalence of Cardiovascular and Respiratory Diseases
4.2.3 Rising Initiatives by Government and Various Organizations to Promote Organ Donations
4.3 Market Restraints
4.3.1 High Cost of the Devices and Organ Transplantation
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Normothermic Machine Perfusion
5.1.2 Hypothermic Machine Perfusion
5.2 By Type of Organ
5.2.1 Heart
5.2.2 Lung
5.2.3 Kidney
5.2.4 Liver
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bridge to Life (Europe) Ltd.
6.1.2 Organ Assist B.V.
6.1.3 Organ Recovery Systems, Inc
6.1.4 OrganOx Limited
6.1.5 Paragonix Technologies, Inc.
6.1.6 Preservation Solutions Inc
6.1.7 TransMedics, Inc.
6.1.8 Waters Medical Systems LLC
6.1.9 XVIVO Perfusion AB
7 MARKET OPPORTUNITIES AND FUTURE TRENDS